• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.45% Nasdaq Up0.40%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    13.38 Down 0.27(1.98%) 4:00PM EDT
    |After Hours : 13.38 0.00 (0.00%) 4:40PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 39,370   59,952   22,661   108,801  
    Cost of Revenue8,364  6,760  10,534  8,444  
    Gross Profit 31,006   53,192   12,127   100,357  
    Operating Expenses
    Research Development47,135  43,229  45,412  47,011  
    Selling General and Administrative13,235  9,544  10,184  10,303  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (29,364) 419   (43,469) 43,043  
    Income from Continuing Operations
    Total Other Income/Expenses Net(13,754)898  246  211  
    Earnings Before Interest And Taxes(43,118)1,317  (43,223)43,254  
    Interest Expense10,982  9,428  9,270  9,221  
    Income Before Tax(54,100)(8,111)(52,493)34,033  
    Income Tax Expense37  92  164  213  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(68,216)(8,203)(52,657)33,820  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (54,137) (8,203) (52,657) 33,820  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (54,137) (8,203) (52,657) 33,820  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.